CG Oncology is based in Irvine, California. It has raised $200M in total funding. Latest round: IPO.
CG Oncology funding overview
CG Oncology is based in Irvine, California. CG Oncology has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in January 2024. The round record for CG Oncology runs through 2024; nothing later has been disclosed. Investors on record include ORI Capital, Longitude Capital, Decheng Capital, ORI Healthcare Fund, Kissei Pharmaceutical, Lepu Medical and 3 others. 9 distinct backers are named across the disclosed rounds.
CG Oncology at a glance
Total raised
$200M
Latest round
IPO
Latest round date
January 2024
Headquarters
Irvine, California
Notable investors
ORI Capital, Longitude Capital, Decheng Capital, ORI Healthcare Fund, Kissei Pharmaceutical, Lepu Medical, Camford Capital, Perseverance Capital Management
Frequently asked about CG Oncology funding
How much has CG Oncology raised?
CG Oncology has raised $200M in total disclosed funding across the rounds on record.
Who has invested in CG Oncology?
ORI Capital, Longitude Capital, Decheng Capital, ORI Healthcare Fund, Kissei Pharmaceutical, Lepu Medical are named among the investors backing CG Oncology.
What was the latest CG Oncology funding round?
The most recent disclosed round is an IPO, announced in January 2024.
Where is CG Oncology based?
CG Oncology is based in Irvine, California.
When did CG Oncology last raise?
The last disclosed CG Oncology round closed in January 2024 at IPO.
Every CG Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Irvine at a similar stage.
